Clinical trial
Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%
NCT00377546 · Innovative Medical, Industry · Completed
Key facts
| NCT number | NCT00377546 |
|---|---|
| Title | Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1% |
| Lead sponsor | Innovative Medical, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Vitrectomy |
| Intervention type | Drug |
| Interventions | Nepafenac, Ketorolac LS, Bromfenac |
| First posted | Sep 18, 2006 |
| Last update posted | Sep 25, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: